Last chance to book
- 00Days
- 00Hrs
- 00Mins
- 00Secs
RNA breakthroughs, Case Studies and Partnerships
September 10-11, 2025Thomas M. Menino Convention & Exhibition Center Michael KhanCEO at ARGONAUTE RNA LIMITEDSpeaker
Profile
CEO Dr Michael Khan, BSc, MBBS, PhD, FRCP. Formerly Head of Molecular Medicine at Warwick University. Formerly CMO of Silence Therapeutics. Senior Clinician and Dyslipidaemia expert. Has taken siRNA drugs from pre-clinical to Phase II. Runs Europe's leading Lp(a) screening service. Expert advisor to EC and NICE , establishing UK guidelines for management of cardiovascular diseases.
Agenda Sessions
A Validated Therapeutic for Tackling Residual Risk in Cardiometabolic Diseases via Bispecific Gene Silencing
, 2:40pmView Session